|
MRPL30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.085000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.694000E-01 |
| Normal-vs-Stage2 |
4.607600E-01 |
| Normal-vs-Stage3 |
3.180600E-01 |
| Normal-vs-Stage4 |
1.585780E-01 |
| Stage1-vs-Stage2 |
3.014200E-01 |
| Stage1-vs-Stage3 |
1.558780E-01 |
| Stage1-vs-Stage4 |
2.923800E-02 |
| Stage2-vs-Stage3 |
8.671200E-01 |
| Stage2-vs-Stage4 |
3.205400E-01 |
| Stage3-vs-Stage4 |
3.895400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.896200E-01 |
| Normal-vs-AfricanAmerican |
4.082600E-01 |
| Normal-vs-Asian |
3.717400E-01 |
| Caucasian-vs-AfricanAmerican |
6.534800E-01 |
| Caucasian-vs-Asian |
3.446000E-01 |
| AfricanAmerican-vs-Asian |
5.188400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.559200E-01 |
| Normal-vs-Female |
9.283000E-03 |
| Male-vs-Female |
4.916300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.652200E-01 |
| Normal-vs-Extreme_Weight |
7.296800E-01 |
| Normal-vs-Obese |
6.455400E-01 |
| Normal-vs-Extreme_Obese |
5.634000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.950000E-01 |
| Normal_Weight-vs-Obese |
5.294800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.120000E-01 |
| Extreme_Weight-vs-Obese |
4.900800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.072400E-01 |
| Obese-vs-Extreme_Obese |
6.517000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.047600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.631500E-02 |
| Normal-vs-Age(61-80Yrs) |
8.606000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.071780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.688800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.457800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.607900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.192100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.647500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.452800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.611200E-01 |
| Normal-VS-Type2 PRCC |
1.410790E-01 |
| Normal-VS-KIRP CIMP |
8.917800E-01 |
| Normal-VS-Unclassified PRCC |
7.587800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.195800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.318800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.355800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.278000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.750600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.984000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.722800E-01 |
| Normal-vs-N1 |
4.264300E-02 |
| Normal-vs-N2 |
3.416600E-01 |
| N0-vs-N1 |
3.011700E-02 |
| N0-vs-N2 |
1.966380E-01 |
| N1-vs-N2 |
9.337600E-01 |
|
|
